Johnson & Johnson Innovation - JLABS Overview
- Investor Type
- Accelerator/Incubator
- Status
- Active
- Professionals
- 1

- Investments
- 389
- Portfolio
- 329
- Exits
- 59

Johnson & Johnson Innovation - JLABS General Information
Description
Founded in 2012, Johnson & Johnson Innovation (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer, and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. The firm achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. The firm is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. The firm also produces campaigns to seek out the best science called QuickFire Challenges. Beyond the growing network of incubation capabilities around the world, the firm is part of the larger Johnson & Johnson Innovation family of companies, which includes Johnson & Johnson Innovation centers, housing our deal teams and therapeutic experts for early-stage development, Johnson & Johnson Innovation - JJDC, Inc., the established venture capital arm, and Johnson & Johnson Innovation - BD, the business development group focusing on later-stage development. What that means for young companies is that, no matter what stage you're at, the firm provides access to all the elements you need to develop your science and to position your company for success.
Contact Information
- 3210 Merryfield Row
- San Diego, CA 92121
- United States
Johnson & Johnson Innovation - JLABS Investments (389)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Aro Biotherapeutics | 23-Nov-2021 | Early Stage VC | 000.00 | Biotechnology | Product Development | |
0000 000000 | 16-Nov-2021 | 00000 00000 | 0000 | Therapeutic Devices | Generating Revenue | |
000000 | 01-Sep-2021 | 000000000000 | 0000 | Other Healthcare Services | Generating Revenue | |
0000000 0000000000 | 21-Jan-2021 | 000000000000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | |
0000 000000000 | 27-Aug-2020 | 000000000000 | Other Healthcare Technology Systems | Generating Revenue | ||
0000000 000000 | 20-Jan-2020 | 00000 00000 | 00.000 | Clinics/Outpatient Services | Generating Revenue | |
00000000000 | 01-Jan-2020 | 000000000000 | Drug Discovery | Generating Revenue | ||
0000000 0000000000 | 05-Dec-2019 | 000000000000 | Biotechnology | Generating Revenue/Not Profitable | ||
Clairways | 17-Oct-2019 | Accelerator/Incubator | Monitoring Equipment | Generating Revenue | 0000 00 0000 | |
Respirix | 26-Sep-2019 | Grant | 0000 | Monitoring Equipment | Clinical Trials - Phase 1 |
Johnson & Johnson Innovation - JLABS Exits (59)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Belite Bio | 29-Apr-2022 | IPO | 0000 |
0000000 0000000000 | 25-Feb-2022 | 000000000000000000 | 000 |
0000 0000 00000000 | 25-Jan-2022 | 0000000000 | |
0000000 | 01-Jan-2022 | 000 00 00000000 | |
000000000000 | 15-Dec-2021 | 000 | 000.00 |
0000000 0000000000 | 04-Nov-2021 | 000 | 00000 |
000000000 | 21-Oct-2021 | 000000000000000000 | 000.00 |
0000000 | 20-Sep-2021 | 000000000000000000 | 00000 |
Tyra Biosciences | 15-Sep-2021 | IPO | 00000 |
Decoy Biosystems | 03-Aug-2021 | Merger/Acquisition | 0000 |
Johnson & Johnson Innovation - JLABS Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialJohnson & Johnson Innovation - JLABS Team (18)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Chelsea Hewitt | Head of Marketing & Global Innovation Activation Leader | San Francisco, CA | |||
Melinda Richter | Global Head, Johnson & Johnson Innovation | 00 | San Francisco, CA | ||
Elena Fernandez-Kleinlein | Head at JLABS | Cambridge, MA | |||
Sharon Chan Ph.D | Head JLABS | 0 | Shanghai, China | ||
Allan Miranda Ph.D | Head, JLABS Canada | 0 | Toronto, Canada |
Johnson & Johnson Innovation - JLABS Co-Investors (51)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Johnson & Johnson Innovation - JJDC | 3 | 0 |
![]() |
![]() |
|
MBC BioLabs | 0 |
![]() |
![]() |
||
ARCH Venture Partners | 0 | 0 |
![]() |
![]() |
|
Baird Capital | 0 | 0 |
![]() |
![]() |
|
Ionis Pharmaceuticals | 0 |
![]() |
![]() |